(Q34516483)

2 August 2017

Elimination of nadolol by patients with renal impairment (English)

1 reference

2 August 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2125.1979.TB04694.X

1 November 2022

author name string

J. Herrera

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A37878

1 November 2022

R. A. Vukovich

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A37878

1 November 2022

D. L. Griffith

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A37878

1 November 2022

language of work or name

English

0 references

publication date

1 January 1979

1 reference

full work available at URL

2 August 2017

https://europepmc.org/articles/PMC1429334

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A37878

https://europepmc.org/articles/PMC1429334?pdf=render

1 November 2022

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A37878

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2125.1979.tb04694.x

1 November 2022

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1111/J.1365-2125.1979.TB04694.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2125.1979.tb04694.x/fullpdf

1 November 2022

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1111/J.1365-2125.1979.TB04694.X

British Journal of Clinical Pharmacology

1 November 2022

published in

1 reference

2 August 2017

7 Suppl 2

1 reference

2 August 2017

227S-231S

1 reference

Drug dosage in patients with impaired renal function

2 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1429334

Pharmacology of nadolol (SQ 11725), a β-adrenergic antagonist lacking direct myocardial depression

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1429334

Comparison of the new beta-adrenoceptor antagonist, nadolol, and propranolol in the treatment of angina pectoris

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1429334

Dose-ranging study of the new beta-adrenergic antagonist nadolol in the treatment of essential hypertension

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1429334

Fluorometric Determination of Nadolol in Human Serum and Urine

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1429334

Metabolic Studies in Patients with Nadolol: Oral and Intravenous Administration

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1429334

Studies on the epidemiology of adverse drug reactions. V. Clinical factors influencing susceptibility

7 July 2018

1 reference

12 December 2020

Pharmacokinetics and hemodialyzability of cefazolin in uremic patients

1 reference

12 December 2020

Elimination of furosemide in healthy subjects and in those with renal failure

1 reference

12 December 2020

Pharmacokinetics and hepatic extraction ratio of pindolol in hypertensive patients with normal and impaired renal function

1 reference

12 December 2020

Identifiers

DOI

1 reference

2 August 2017

1 reference

2 August 2017

1 reference